Kevin Outterson interviewed by The New England Journal of Medicine on "The FDA's Guidance on Off-Label Promotion and the Move Toward Clinical Trial Transparency"

07.09.14

Kevin Outterson interviewed by The New England Journal of Medicine on "The FDA's Guidance on Off-Label Promotion and the Move Toward Clinical Trial Transparency"